Gunjan Arora
About Gunjan Arora
Gunjan Arora is an Associate Research Scientist at Yale University, recognized for her work on immunomodulatory proteins in malaria and Lyme disease. She has an extensive academic background in biotechnology and has held various research positions, including at the National Institutes of Health and the Translational Health Science & Technology Institute.
Work at Yale University
Gunjan Arora has been employed at Yale University as an Associate Research Scientist since 2018. In this role, she focuses on identifying molecular immune mechanisms related to mRNA-LNP based anti-tick vaccines. Her work contributes to advancing the understanding of immunology and vaccine development.
Education and Expertise
Gunjan Arora holds multiple degrees in the fields of biotechnology and related sciences. She completed her Bachelor of Science (B.Sc.) in Biotechnology, Chemistry, and Zoology at the University of Rajasthan from 2001 to 2004. She earned a Master's in Marine Biotechnology from Goa University between 2004 and 2006. Arora obtained her Doctor of Philosophy (Ph.D.) from CSIR-Institute of Genomics and Integrative Biology from 2006 to 2011. Additionally, she completed an Executive MBA at Quantic School of Business and Technology from 2020 to 2021.
Background in Research
Prior to her current position at Yale University, Gunjan Arora worked at the National Institutes of Health as a Postdoctoral Fellow from 2013 to 2018. She also served as a Postdoctoral Fellow at the CSIR-Institute of Genomics and Integrative Biology from 2011 to 2013. Earlier in her career, she was recognized as a Vaccine Research Innovation Awardee at the Translational Health Science & Technology Institute in India for a six-month period in 2013.
Research Contributions
Gunjan Arora has made significant contributions to the field of immunology. She discovered the role of AgSAP, an immunomodulatory protein, in the early-stage infection of the malaria parasite. Additionally, she identified the role of PGLYRP1, an innate immune protein, in Lyme disease through the use of human secretome libraries and mouse models. Her research focuses on understanding immune responses and developing innovative vaccine strategies.